3656 results for «392»

Filter By

3656 results

How should I treat a patient with multivessel disease - A patient's journey

04 Mar 2023 – From AfricaPCR 2023

In this session, study the case of a 55-year-old female patient with DM and previous inferior STEMI, who presented with minimal exertion angina, 48% EF and mild MR, and follow her journey to understand how to optimally handle the specifics of patients with multivessel disease.

How should I treat a patient with multivessel disease - A patient's journey

Calcified left main bifurcation PCI: how to evaluate and how best to treat - LIVE case

04 Mar 2023 – From AfricaPCR 2023

A 62-year-old male with hormonal treatment (metastatic prostate carcinoma) presents an exertion angina due to an MVD: severe calcified stenoses of distal left main (medina 1-1-1), mid LAD and prox CX.
Watch how the operators prepare LAD and CX lesions with Rotablator (Burrs: 1.25 + 1.75) then...

Calcified left main bifurcation PCI

Calcification clinical cases

04 Mar 2023 – From AfricaPCR 2023

Learn more about transcatheter lithotripsy for aortic subvalvar calcification or LIMA and left anterior descending perforation in this session dedicated to calcification which includes 5 different clinical cases.

Calcification clinical cases

How should I treat a patient with bifurcation coronary disease - A patient's journey

04 Mar 2023 – From AfricaPCR 2023

Consider the case of a 66-year-old male patient with no previous cardiac history, but HTN for 20 years, presenting after a successfully thrombolysed inferior STEMI within the 12 hours, no other immediately obvious risk factor for IHD, good baseline functional capacity and normal bio-profile, and compare...

How should I treat a patient with bifurcation coronary disease - A patient's journey

Transcatheter dilatation of aorta coarctation in a 5-month-old baby - LIVE case

04 Mar 2023 – From AfricaPCR 2023

A 5-month-old baby girl with hypoplastic left heart syndrome was born at term (3 Kg) with associated large ASD secundum. A surgical repaired aortic arch with ASD and PDA closing was performed at 2 weeks old. At 5 months, she presented a re-coarctation of the aorta (65...

Coarctation of aorta, balloon angioplasty of recurrent coarctation following surgical repair

How should I treat a patient with STEMI - A patient's journey

04 Mar 2023 – From AfricaPCR 2023

The case presented in this session is that of a 39-year-old mother and housewife, diabetic for 5 years, who was transferred to the hub for primary PCI and found to have an acute inferior STEMI: follow her journey and the discussions around her treatment management.

How should I treat a patient with STEMI - A patient's journey

Intervention makes a difference

04 Mar 2023 – From AfricaPCR 2023

This AfricaPCR 2023 session includes presentations of 5 cases highlighting the importance of percutaneous interventions, which often have a considerable impact on the patients who undergo them.

Intervention makes a difference

Coronary clinical cases - session 3

04 Mar 2023 – From AfricaPCR 2023

Among the 6 presentations offered in this AfricaPCR 2023 session, find out more about a multivessel PCI and tight aortic stenosis, the case of a 6-year-old boy with HTN and dilated cardiomyopathy, a hybrid SVG calcium modification, and rare complications in a TAVI case.

Coronary clinical cases - session 3

Why hypertension is a major unresolved problem

02 Oct 2024

Explore the global challenge of hypertension, affecting one in three adults, and the strategies for screening, diagnosis, and management, including lifestyle modifications, pharmacotherapy, and device-based treatments, as outlined by Sofie Brouwers.

Sofie Brouwers

Author

Sofie Brouwers
Why hypertension is a major unresolved problem

Which AF patients may benefit from LAA closure?

02 Jul 2026

Martin Bergmann reviews the evolving evidence for LAAC, examining how recent landmark trials such as OPTION, CLOSURE‑AF and CHAMPION‑AF are reshaping patient selection and expanding the role of LAAC across a broader spectrum of patients with atrial fibrillation.

Martin W. Bergmann

Author

Martin W. Bergmann
Which AF patients may benefit from LAA Closure?

TRISCEND II: Two-year outcomes of transcatheter tricuspid valve replacement for severe tricuspid regurgitation

31 Mar 2026

Jonathan Curio provides his take on TRISCEND II trial results presented by Vinod H. Thourani at ACC.26 in New Orleans.

Jonathan Curio

Author

Jonathan Curio
TRISCEND II: Two-Year Outcomes Of Transcatheter Tricuspid Valve Replacement For Severe Tricuspid Regurgitation

BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

07 Nov 2022

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Nicola Ryan

Author

Nicola Ryan
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

From PROTECT-AF to CHAMPION-AF: Where do we stand today?

01 Jul 2026

In this article, Jens Erik Nielsen-Kudsk reviews the evolution of left atrial appendage closure, from early trials such as PROTECT‑AF to recent evidence including CHAMPION‑AF, and discusses its expanding role in stroke prevention for atrial fibrillation.

Jens-Erik-Nielsen-Kudsk

Author

Jens Erik Nielsen-Kudsk
From PROTECT-AF to CHAMPION-AF: Where do we stand today?

Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions

08 Jan 2025

In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.

Author

Bruno Scheller
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions

Evidence base: A description of the key, so far published, studies in the space of drug coated balloons

23 Jan 2025

Authored by Hector Garcia-Garcia and Jorge Sanz-Sanchez, this article examines pivotal randomized clinical trials on drug-coated balloons in coronary artery disease. It highlights their role in managing in-stent restenosis, de novo small vessel lesions, and large vessel lesions while exploring future directions through ongoing trials.

Author

Hector Garcia-Garcia
Jorge Sanz Sanchez

Author

Jorge Sanz-Sanchez
Evidence base: A description of the key, so far published, studies in the space of drug coated balloons

NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome

02 Sep 2025

Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...

Daniele Giacoppo

Author

Daniele Giacoppo
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
Didn’t find what you were looking for?